Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5851
Avantor
AVTR
$9.32B
| $22K | ﹤0.01% |
1,200
-20,636
| -95% | -$328K |
|
5852
Sprott Physical Gold and Silver Trust
CEF
$7.4B
| $22K | ﹤0.01% |
1,500
-800
| -35% | -$11.5K |
|
|
VISN
5853
Vistance Networks Inc
VISN
$2.65B
| $22K | ﹤0.01% |
1,576
-76,464
| -98% | -$992K |
|
5854
Cardiff Oncology
CRDF
$66.5M
| $22K | ﹤0.01% |
18,057
+17,709
| +5,089% | +$25.2K |
|
|
AGIG
5855
Abundia Global Impact Group
AGIG
$42.5M
| $22K | ﹤0.01% |
+1,212
| New | +$24.9K |
|
5856
PUT
ITT
ITT
$17.5B
| $22K | ﹤0.01% |
300
-100
| -25% | -$6.64K |
|
|
JKS
5857
JinkoSolar
JKS
$777M
| $22K | ﹤0.01% |
976
-122,356
| -99% | -$2.14M |
|
5858
PUT
St. Joe Company
JOE
$3.54B
| $22K | ﹤0.01% |
1,100
+100
| +10% | +$1.85K |
|
|
MRSH
5859
CALL
Marsh
MRSH
$90.5B
| $22K | ﹤0.01% |
200
-6,300
| -97% | -$658K |
|
5860
Prospect Capital
PSEC
$1.07B
| $22K | ﹤0.01% |
3,551
+1,483
| +72% | +$9.66K |
|
|
ONIT
5861
PUT
Onity Group
ONIT
$309M
| $22K | ﹤0.01% |
1,060
-240
| -18% | -$5.81K |
|
|
WRI
5862
PUT
DELISTED
Weingarten Realty Investors
WRI
| $22K | ﹤0.01% |
700
| – | – |
|
5863
CALL
Applied Optoelectronics
AAOI
$7.57B
| $21K | ﹤0.01% |
1,800
| – | – |
|
5864
Invesco DB Base Metals Fund
DBB
$312M
| $21K | ﹤0.01% |
1,418
-400
| -22% | -$6.03K |
|
5865
ProShares Ultra Dow30
DDM
$542M
| $21K | ﹤0.01% |
+766
| New | +$19.9K |
|
5866
CALL
Dolby
DLB
$5.51B
| $21K | ﹤0.01% |
300
-200
| -40% | -$13.2K |
|
5867
electroCore
ECOR
$54.9M
| $21K | ﹤0.01% |
883
+441
| +100% | +$11.2K |
|
5868
PUT
Northern Trust
NTRS
$33.3B
| $21K | ﹤0.01% |
200
-500
| -71% | -$51.2K |
|
5869
Outlook Therapeutics
OTLK
$183M
| $21K | ﹤0.01% |
+1,761
| New | +$41K |
|
5870
CALL
Pool Corp
POOL
$6.75B
| $21K | ﹤0.01% |
100
-900
| -90% | -$186K |
|
5871
PUT
ProShares Ultra Financials
UYG
$828M
| $21K | ﹤0.01% |
400
+300
| +300% | +$14.9K |
|
5872
CALL
Worthington Enterprises
WOR
$2.75B
| $21K | ﹤0.01% |
811
-14,922
| -95% | -$351K |
|
|
XIN
5873
DELISTED
Xinyuan Real Estate
XIN
| $21K | ﹤0.01% |
558
+222
| +66% | +$8.75K |
|
|
XIN
5874
PUT
DELISTED
Xinyuan Real Estate
XIN
| $21K | ﹤0.01% |
560
+510
| +1,020% | +$20.1K |
|
5875
PUT
Bruker
BRKR
$9.57B
| $20K | ﹤0.01% |
+400
| New | +$19K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.